Composition and Method for Treating Metabolic Disorders

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15492891

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Bromocriptine citrate administered to a vertebrate, animal or human, can be used for any purpose including, e.g., the long-term modification and regulation of metabolic disorders, including prediabetes, obesity, insulin resistance, hyperinsulinemia, hyperglycemia and type 2 diabetes mellitus (T2DM) and/or, e.g., the treatment of other medical disorder(s) including immune or endocrine disorders or diseases. Bromocriptine citrate is administered over a limited or extended period at a time of day dependent on re-establishing the normal circadian rhythm of central dopaminergic activity of healthy members of a similar species and sex. Insulin resistance, hyperinsulinemia and hyperglycemia, T2DM, prediabetes, MS or all, can be controlled in humans on a long term basis by such treatment inasmuch as the daily administration of bromocriptine citrate resets neuronal activity timing in the neural centers of the brain to produce long term effects.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VEROSCIENCE LLC1334 MAIN ROAD TIVERTON RI 02878

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cincotta, Anthony H Tiverton, US 112 2663

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation